PIK3CA and lung cancer: The comparative studies revealed that the Chinese cohort had a significantly higher frequency of PIK3CA mutations in large intestine, kidney, and lung cancers, but a markedly lower mutation frequency in breast and stomach cancers than the COSMIC cohort.